Cell Line Development Market Predicting 13% CAGR Growth by 2024:Top Players: GE Healthcare, Sigma-Aldrich, Cytovance Biologics
The Cell Line Development Market is set to exceed USD 7.5 billion by 2024; according to a new research report by Global Market Insights. Rising incidence of chronic diseases such as cancer, autoimmune disease and inflammatory disorders will drive the global cell line development market during the forecast period. Rapidly growing geriatric population base and unmet need for cancer drugs are the key factors that will fuel the demand for discovery of new drugs, thereby accelerating cell line development industry...
View full press release